Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2010-5-18
pubmed:abstractText
Bisphosphonates are the most commonly used drugs for the prevention and treatment of osteoporosis. Although a recent FDA review of the results of clinical trials reported no clear link between bisphosphonates and serious or non-serious atrial fibrillation (AF), some epidemiologic studies have suggested an association between AF and bisphosphonates.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/20170505-10789670, http://linkedlifedata.com/resource/pubmed/commentcorrection/20170505-11004419, http://linkedlifedata.com/resource/pubmed/commentcorrection/20170505-11576817, http://linkedlifedata.com/resource/pubmed/commentcorrection/20170505-11732644, http://linkedlifedata.com/resource/pubmed/commentcorrection/20170505-12111919, http://linkedlifedata.com/resource/pubmed/commentcorrection/20170505-12428993, http://linkedlifedata.com/resource/pubmed/commentcorrection/20170505-14623805, http://linkedlifedata.com/resource/pubmed/commentcorrection/20170505-14651779, http://linkedlifedata.com/resource/pubmed/commentcorrection/20170505-16278230, http://linkedlifedata.com/resource/pubmed/commentcorrection/20170505-16427496, http://linkedlifedata.com/resource/pubmed/commentcorrection/20170505-16682576, http://linkedlifedata.com/resource/pubmed/commentcorrection/20170505-17144789, http://linkedlifedata.com/resource/pubmed/commentcorrection/20170505-17476007, http://linkedlifedata.com/resource/pubmed/commentcorrection/20170505-17476024, http://linkedlifedata.com/resource/pubmed/commentcorrection/20170505-17703529, http://linkedlifedata.com/resource/pubmed/commentcorrection/20170505-17878149, http://linkedlifedata.com/resource/pubmed/commentcorrection/20170505-18334527, http://linkedlifedata.com/resource/pubmed/commentcorrection/20170505-18443257, http://linkedlifedata.com/resource/pubmed/commentcorrection/20170505-18832388, http://linkedlifedata.com/resource/pubmed/commentcorrection/20170505-19141097, http://linkedlifedata.com/resource/pubmed/commentcorrection/20170505-19266096, http://linkedlifedata.com/resource/pubmed/commentcorrection/20170505-19268739, http://linkedlifedata.com/resource/pubmed/commentcorrection/20170505-19338379, http://linkedlifedata.com/resource/pubmed/commentcorrection/20170505-19412101, http://linkedlifedata.com/resource/pubmed/commentcorrection/20170505-19680161, http://linkedlifedata.com/resource/pubmed/commentcorrection/20170505-19772579, http://linkedlifedata.com/resource/pubmed/commentcorrection/20170505-3802833, http://linkedlifedata.com/resource/pubmed/commentcorrection/20170505-7864703, http://linkedlifedata.com/resource/pubmed/commentcorrection/20170505-8950879, http://linkedlifedata.com/resource/pubmed/commentcorrection/20170505-9832001
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1478-6362
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
12
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
R30
pubmed:dateRevised
2011-5-11
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Bisphosphonates and risk of atrial fibrillation: a meta-analysis.
pubmed:affiliation
Division of Rheumatology, Allergy and Immunology, Department of Medicine, Brigham and Women's Hospital, 75 Francis Street, Boston, MA, 02115, USA. skim62@partners.org
pubmed:publicationType
Journal Article, Meta-Analysis, Research Support, N.I.H., Extramural